Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary ZIOPHARM Oncology Information Available through S&P Market Access Program
ZIOPHARM Oncology Information Available through S&P Market Access Program NEW YORK, NY - January 06, 2006 - ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announced today that its company information will be made available via Standard & Poor's Market Access Program, an information distribution service
View HTML
Toggle Summary ZIOPHARM Oncology Accomplishes Key Clinical Development Milestone
-- Receives FDA Clearance to Initiate ZIO-101 Phase I/II Myeloma Trial --
View HTML
Toggle Summary ZIOPHARM Oncology Announces ZIO-201 ASH Abstract Publication View HTML
Toggle Summary ZIOPHARM Oncology Announces ZIO-101 Data Published in Blood View HTML
Toggle Summary ZIOPHARM Oncology Announces ZIO-102 Data Presented at AACR-NCI-EORTC International Conference View HTML
Toggle Summary ZIOPHARM Oncology Announces ZIO-101 Phase I Data Presented at AACR-NCI-EORTC International Conference
Novel Organic Arsenic Evidences Both Safety and Activity
View HTML
Toggle Summary ZIOPHARM Oncology to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference View HTML
Toggle Summary ZIOPHARM Oncology to Present at MASS Opportunities Partnering Forum View HTML
Toggle Summary ZIOPHARM Oncology to Present at C.E. Unterberg, Towbin Life Sciences Conference View HTML
Toggle Summary ZIOPHARM Oncology to Present at Bio Investor Forum View HTML